Sponsor:
Columbia University
Code:
NCT05010603
Conditions
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Accepted
Interventions
Blood Draw
Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
Brief summary:
Conditions
Alzheimer Disease
Study ID
NCT05010603
Start date
Nov 15, 2016
Status verified date
May, 2026
Completion date
Apr 30, 2027
Anticipated
Primary completion date
Apr 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Accepted
Enrollment
10000 participants
Anticipated
Arms
Families with a history of Alzheimer's Disease
Un-related, non-demented controls
Individuals with Dementia (Alzheimer's Disease)
Interventions
Blood Draw
Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
Primary outcome measure
Central contacts
Locations
University of Washington
Recruiting
Washington D.C., District of Columbia, United States, 98105
University of Miami
Recruiting
Miami, Florida, United States, 33124
Rush University
Recruiting
Aurora, Illinois, United States, 60612
Indiana University
Recruiting
Bloomington, Indiana, United States, 47405
NCRAD at Indiana University
Recruiting
Indianapolis, Indiana, United States, 46202
Mayo Clinic
Recruiting
Rochester, Minnesota, United States, 55901
Joanne Norton
Recruiting
St Louis, Missouri, United States, 63130
Columbia University Irving Medical Center
Recruiting
New York, New York, United States, 10032
Contacts
Principal Investigator:
Richard P Mayeux, MD, MSc
North Carolina State University
Recruiting
Raleigh, North Carolina, United States, 27695
University of Pittsburgh
Recruiting
Pittsburgh, Pennsylvania, United States, 15213
University of Texas Southwestern
Recruiting
Dallas, Texas, United States, 75390
University of Washington
Recruiting
Seattle, Washington, United States, 98195
Sponsor
Columbia University
Last update posted
May 18, 2026
Last verified
May, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Columbia University on 2026-05-18.